ArticleNature communications2021

MAPK-pathway inhibition mediates inflammatory reprogramming and sensitizes tumors to targeted activation of innate immunity sensor RIG-I.

Johannes Brägelmann et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.